AI
Healthcare organizations and technology companies must work together to ensure responsible and ethical AI use and to explore the true benefits of AI.
The companies will leverage Absci's AI-enabled Integrated Drug Creation platform and the pharma giant's oncology research and development expertise.
It has also obtained its third US FDA 510(k) clearance.
Heidi Health recently raised $6.5 million in Series A funding for its nationwide expansion.
It also intends to triple its consumer base.
The pair will work to further the practice of radiology and patient care using innovation, such as theranostics, AI and digital health platforms.
The funding will support the University of Melbourne-led project's pilot in Australia.
Fifteen projects, including eight digital health initiatives, received $3 million in cash, Google Cloud credits and technical assistance.
The algorithm helps predict missed appointments, failure to schedule follow-up visits and late arrivals.
The company will use the funds to bring its AI-enabled offerings into clinical development and advance its platform and portfolio.